Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand Announces 2025 Investor Day in New York City

JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at...
May 14, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
May 08, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand Reports First Quarter 2025 Financial Results

Ligand Reports First Quarter 2025 Financial Results
May 01, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand to Participate in May Investor Conferences

Ligand to Participate in May Investor Conferences
April 24, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
April 17, 2025 06:00 ET | Source: Ligand Pharmaceuticals

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
March 03, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand to Participate in March Investor Conferences

Ligand to Participate in March Investor Conferences
February 27, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
February 25, 2025 07:00 ET | Source: Ligand Pharmaceuticals

Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences

Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences